Aziyo Biologics names chief scientific officer


Aziyo Biologics named Michelle Williams, PhD, as chief scientist, the regenerative medicine company said Aug. 26.

Dr. Williams previously worked in the same capacity at Osiris Therapeutics, according to a news release. She is a fellow in the American Institute for Medical and Biological Engineering.

"Michelle has been a thought leader in regenerative medicine for two decades," Randy Mills, PhD, CEO of Aziyo, said in the release. "She has a track record of consistently developing commercially successful products, including Osteocel, the world’s first stem cell product with cumulative sales of over $1 billion. We believe her ability to develop great products, backed by strong science and through efficient use of capital, will create significant value for Aziyo."

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers